CA
AGIO icon

Clearstead Advisors’s Agios Pharmaceuticals AGIO Stock Holding History

Clearstead Advisors’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.34K Buy
+63
New +$1.91K ﹤0.01% 2426
2025
Q4 		– Sell
-291
Closed -$11.7K – 2747
2025
Q3 		$11.7K Hold
291
– – ﹤0.01% 1877
2025
Q2 		$9.68K Buy
+291
New +$8.82K ﹤0.01% 1904

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Clearstead Advisors's AGIO Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2026: 63 shares worth $2.34K. The stake represents ﹤0.01% of the portfolio and ranks #2426 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in AGIO as recently as Q3 2025.

Clearstead Advisors first reported a position in AGIO in Q2 2025 and has held it in 3 quarters since. The position peaked at $11.7K in Q3 2025. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Clearstead Advisors held 63 shares of Agios Pharmaceuticals worth $2.34K as of Q2 2026.
  • Agios Pharmaceuticals was a new Clearstead Advisors position in Q2 2026.
  • Agios Pharmaceuticals made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #2426 holding.
  • Clearstead Advisors first reported a position in Agios Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • Clearstead Advisors's Agios Pharmaceuticals position peaked at $11.7K in Q3 2025.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.